Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2014 (2014), Article ID 475480, 11 pages
http://dx.doi.org/10.1155/2014/475480
Research Article

Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy

1Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Institute of Hypertension, 197 Ruijin Road, Shanghai 200025, China
2Nippon Boehringer Ingelheim Co., Ltd , 2-1-1, Osaki, Shinagawa-ku, Tokyo 141-6017, Japan
3Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Straße 173, 55216 Ingelheim, Germany

Received 6 November 2013; Accepted 15 January 2014; Published 27 February 2014

Academic Editor: Claudio Borghi

Copyright © 2014 Dingliang Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Martiniuk, C. M. Lee, C. M. M. Lawes et al., “Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region,” Journal of Hypertension, vol. 25, no. 1, pp. 73–79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Ueshima, O. Iimura, M. Iida, A. Okayama, K. Sawai, and M. Minowa, “Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese—nippon data 80,” Journal of Human Hypertension, vol. 17, no. 12, pp. 851–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Miura, “Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity?” EPMA Journal, vol. 2, no. 1, pp. 59–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Okayama, T. Kadowaki, T. Okamura, T. Hayakawa, and H. Ueshima, “Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80),” Journal of Hypertension, vol. 24, no. 3, pp. 459–462, 2006. View at Google Scholar · View at Scopus
  5. D. Gu, T. N. Kelly, X. Wu et al., “Blood pressure and risk of cardiovascular disease in chinese men and women,” The American Journal of Hypertension, vol. 21, no. 3, pp. 265–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Murakami, A. Hozawa, T. Okamura, and H. Ueshima, “Relation of blood pressure and all-cause mortality in 180, 000 japanese participants pooled analysis of 13 cohort studies,” Hypertension, vol. 51, no. 6, pp. 1483–1491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Q. Ma, W. H. Mei, P. Yin, X. H. Yang, S. K. Rastegar, and J. D. Yan, “Prevalence of hypertension in Chinese cities: a meta-analysis of published studies,” PLoS ONE, vol. 8, no. 3, Article ID e58302, 2013. View at Google Scholar
  8. C. S. Sheng, M. Liu, Y. Y. Kang et al., “Prevalence, awareness, treatment and control of hypertension in elderly Chinese,” Hypertension Research, vol. 36, no. 9, pp. 824–828, 2013. View at Google Scholar
  9. S. E. Kjeldsen, F. H. Messerli, C. E. Chiang, P. A. Meredith, and L. Liu, “Are fixed-dose combination antihypertensives suitable as first-line therapy?” Current Medical Research and Opinion, vol. 28, no. 10, pp. 1685–1697, 2012. View at Google Scholar
  10. A. H. Gradman, J. N. Basile, B. L. Carter, and G. L. Bakris, “Combination therapy in hypertension,” Journal of the American Society of Hypertension, vol. 4, no. 2, pp. 90–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Mancia, R. Fagard, K. Narkiewicz et al., “ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 34, no. 28, pp. 2159–2219, 2013. View at Google Scholar
  13. S. Bangalore and L. Ley, “Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations,” Expert Opinion on Pharmacotherapy, vol. 13, no. 3, pp. 345–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Sherrill, M. Halpern, S. Khan, J. Zhang, and S. Panjabi, “Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence,” Journal of Clinical Hypertension, vol. 13, no. 12, pp. 898–909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bangalore, G. Kamalakkannan, S. Parkar, and F. H. Messerli, “Fixed-dose combinations improve medication compliance: a meta-analysis,” The American Journal of Medicine, vol. 120, no. 8, pp. 713–719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Akazawa and K. Fukuoka, “Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis,” BMC Health Services Research, vol. 13, p. 124, 2013. View at Google Scholar
  17. G. Hess, J. Hill, H. Lau, H. Dastani, and P. Chaudhari, “Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy,” P and T, vol. 33, no. 11, pp. 652–666, 2008. View at Google Scholar · View at Scopus
  18. A. K. Gupta, S. Arshad, and N. R. Poulter, “Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis,” Hypertension, vol. 55, no. 2, pp. 399–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Mancia, S. Laurent, E. Agabiti-Rosei et al., “Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document,” Journal of Hypertension, vol. 27, no. 11, pp. 2121–2158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Ogihara, K. Kikuchi, H. Matsuoka et al., “The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009),” Hypertension Research, vol. 32, no. 1, pp. 3–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Neutel, “Treatment algorithms for hypertension: a practical approach,” Clinical Practice, vol. 10, no. 3, pp. 333–344, 2013. View at Google Scholar
  22. A. F. Rubio-Guerra, D. Castro-Serna, C. I. Barrera, and L. M. Ramos-Brizuela, “Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors,” Integrated Blood Pressure Control, vol. 2, pp. 55–62, 2009. View at Google Scholar · View at Scopus
  23. S. G. Mallat, “Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?” Cardiovascular Diabetology, vol. 11, p. 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Yusuf, K. K. Teo, J. Pogue et al., “Telmisartan, ramipril, or both in patients at high risk for vascular events,” The New England Journal of Medicine, vol. 358, no. 15, pp. 1547–1559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Burnier, “Telmisartan: a different angiotensin II receptor blocker protecting a different population?” Journal of International Medical Research, vol. 37, no. 6, pp. 1662–1679, 2009. View at Google Scholar · View at Scopus
  26. D. Galzerano, C. Capogrosso, S. di Michele et al., “New standards in hypertension and cardiovascular risk management: focus on telmisartan,” Vascular Health and Risk Management, vol. 6, no. 1, pp. 113–133, 2010. View at Google Scholar · View at Scopus
  27. A. L. Dans, K. Teo, P. Gao et al., “In a subgroup of high-risk asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events,” PLoS ONE, vol. 5, no. 12, Article ID e13694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Zhu, P. Gao, W. Holtbruegge, and C. Huang, “A randomized, double-blind study to evaluate the efficacy and safety of a singlepill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients,” Journal of International Medical Research, vol. 42, no. 1, pp. 52–66, 2014. View at Google Scholar
  29. P. S. Sever and F. H. Messerli, “Hypertension management 2011: optimal combination therapy,” European Heart Journal, vol. 32, no. 20, pp. 2499–2506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Egan, D. Bandyopadhyay, S. R. Shaftman, C. S. Wagner, Y. Zhao, and K. S. Yu-Isenberg, “Initial monotherapy and combination therapy and hypertension control the first year,” Hypertension, vol. 59, no. 6, pp. 1124–1131, 2012. View at Google Scholar
  31. A. H. Gradman, H. Parise, P. Lefebvre, H. Falvey, M. H. Lafeuille, and M. S. Duh, “Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study,” Hypertension, vol. 61, no. 2, pp. 309–318, 2013. View at Google Scholar
  32. G. Corrao, F. Nicotra, A. Parodi et al., “Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice,” Hypertension, vol. 58, no. 4, pp. 566–572, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. K. Gupta, N. R. Poulter, J. Dobson et al., “Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial,” The American Journal of Hypertension, vol. 23, no. 9, pp. 1023–1030, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Ohishi, T. Kawai, N. Hayashi et al., “Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study,” Hypertension Research, vol. 36, no. 7, pp. 620–626, 2013. View at Google Scholar
  35. H. Bekki, K. Yamamoto, M. Sone et al., “Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 5, pp. 342–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Bekki, K. Yamamoto, M. Sone et al., “Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension,” Clinical Cardiology, vol. 34, no. 4, pp. 261–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Ma, W. Wang, Y. Zhao et al., “Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study,” The American Journal of Cardiovascular Drugs, vol. 12, no. 2, pp. 137–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. T. W. Littlejohn III, C. R. Majul, R. Olvera et al., “Results of treatment with telmisartan-amlodipine in hypertensive patients,” The Journal of Clinical Hypertension, vol. 11, no. 4, pp. 207–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. W. Littlejohn III, C. R. Majul, R. Olvera et al., “Telmisartan plus amlodipine in patients withmoderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial study,” Postgraduate Medicine, vol. 121, no. 2, pp. 5–14, 2009. View at Google Scholar
  40. S. Neldam, M. Lang, and R. Jones, “Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study,” Journal of Clinical Hypertension, vol. 13, no. 7, pp. 459–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Neldam, C. Edwards, and R. Jones, “Switching patients with uncontrolled hypertension on amlodipine 10mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study,” Current Medical Research and Opinion, vol. 27, no. 11, pp. 2145–2153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. W. B. White, T. W. Littlejohn, C. R. Majul et al., “Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension,” Blood Pressure Monitoring, vol. 15, no. 4, pp. 205–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Neutel, G. Mancia, H. R. Black et al., “Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study,” The Journal of Clinical Hypertension, vol. 14, no. 4, pp. 206–215, 2012. View at Google Scholar
  44. R. M. Guthrie, B. Dahlöf, K. A. Jamerson et al., “Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients,” Current Medical Research and Opinion, vol. 27, no. 10, pp. 1995–2008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Ley and H. Schumacher, “Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients),” Current Medical Research and Opinion, vol. 29, no. 1, pp. 41–53, 2013. View at Google Scholar
  46. A. M. Sharma, G. Bakris, J. M. Neutel et al., “Single-pill combination of telmisartan/Amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial,” Clinical Therapeutics, vol. 34, no. 3, pp. 537–551, 2012. View at Publisher · View at Google Scholar · View at Scopus